保肝降酶方质量标志物的预测分析
x

请在关注微信后,向客服人员索取文件
| 篇名: | 保肝降酶方质量标志物的预测分析 |
| TITLE: | Prediction and analysis of Q-marker of Baogan jiangmei formula |
| 摘要: | 目的 预测分析保肝降酶方的质量标志物(Q-Marker)。方法建立15批保肝降酶方的高效液相色谱(HPLC)指纹图谱,通过与对照品比对,指认共有峰。采用HPLC法测定指认成分的含量。借助中药系统药理学数据库与分析平台并检索相关文献,补充指纹图谱未检出的成分,再运用网络药理学构建15个候选成分(11个指认成分+4个补充成分)-疾病(药物性肝损伤)网络,预测保肝降酶方的Q-Marker。结果15批样品的HPLC指纹图谱中共标定出22个共有峰,指认出11个成分,分别为绿原酸(4号峰)、芍药苷(9号峰)、虎杖苷(10号峰)、新落新妇苷(11号峰)、落新妇苷(12号峰)、新异落新妇苷(14号峰)、异落新妇苷(15号峰)、白藜芦醇(16号峰)、迷迭香酸(17号峰)、丹酚酸B(19号峰)、甘草酸铵(22号峰)。15批样品中上述11个成分的含量分别为0.2765~0.3694、1.2184~1.6231、0.1139~0.3964、0.2528~0.8225、0.3111~0.7799、0.2736~0.7529、0.0440~0.1911、0.0131~0.0477、0.1687~0.2756、0.7639~1.9938、0.1191~0.3292mg/g。4个补充成分分别为异鼠李素、温郁金素、莪术内酯、α-亚麻酸。网络药理学分析显示,15个候选成分均可与疾病靶点建立关联;富集功能主要涉及外源性物质刺激应答、脂多糖应答、蛋白激酶活性、转录因子结合、核受体结合等;富集通路主要包含磷脂酰肌醇3-激酶/蛋白激酶B信号通路、肿瘤坏死因子信号通路、缺氧诱导因子1信号通路等。结论绿原酸等15个成分有望成为保肝降酶方干预药物性肝损伤的Q-Marker。 |
| ABSTRACT: | OBJECTIVE To predict and analyze the quality marker(Q-Marker) of Baogan jiangmei formula.METHODS HPLC fingerprints of 15 batches of Baogan jiangmei formula were established, with common peaks identified against reference standards. The contents of characterized components were quantified by HPLC. Components absent in fingerprints were supplemented via TCMSP and literature retrieval. A component (11 identification components + 4 supplementary components)- disease (drug-induced liver injury) network was constructed using network pharmacology to predict the Q-Marker of Baogan jiangmei formula.RESULTS A total of 22 common peaks were identified in the HPLC fingerprints of 15 batches of samples, and 11 chromatographic peaks were identified, namely chlorogenic acid (peak 4), paeoniflorin (peak 9), polydatin (peak 10), neoastilobin (peak 11), astilobin (peak 12), neoisoastilbin (peak 14), isoastilbin (peak 15), resveratrol (peak 16), rosmarinic acid (peak 17), salvianolic acid B (peak 19), and ammonium glycyrrhizinate (peak 22). The contents of 11 components in 15 batches of Baogan jiangmei formula were 0.276 5-0.369 4, 1.218 4-1.623 1, 0.113 9-0.396 4, 0.252 8-0.822 5, 0.311 1-0.779 9, 0.273 6-0.752 9, 0.044 0-0.191 1, 0.013 1-0.047 7, 0.168 7-0.275 6, 0.763 9-1.993 8, 0.119 1-0.329 2 mg/g. Four components, namely isorhamnetin, curzerene, curdione and α -linolenic acid, were supplemented. Network pharmacology analysis showed that the 15 candidate components could interact with the disease targets. Functional enrichment mainly involved the response to exogenous stimulus, lipopolysaccharide response, protein kinase activity, transcription factor binding, nuclear receptor binding, etc. The enriched pathways primarily included the phosphoinositide 3-kinase/protein kinase B, tumor necrosis factor and hypoxia-inducible factor-1 signaling pathways.CONCLUSIONS Chlorogenic acid and the other 14 components are expected to be the Q-Markers of Baogan jiangmei formula for intervening in drug-induced liver injury. |
| 期刊: | 2026年第37卷第21期 |
| 作者: | 孟颖;韩怡;高俪原;杨祥;常晓艳;李杰;柳春娣;木卡代斯·斯依提;蒋志涛 |
| AUTHORS: | MENG Ying,HAN Yi, GAO Liyuan,YANG Xiang,CHANG Xiaoyan,LI Jie,LIU Chundi,Mukadaisi·Siyiti,JIANG Zhitao |
| 关键字: | 保肝降酶方;指纹图谱;多成分含量测定;网络药理学;质量标志物;药物性肝损伤 |
| KEYWORDS: | Baogan jiangmei formula;Fingerprint;multicomponent content determination;Network pharmacology;Quality marker;Drug-induced liver injury |
| 阅读数: | 0 次 |
| 本月下载数: | 0 次 |
* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!
返回
加入收藏










